Tata Chemicals Limited

Tata Chemicals to Meet Kotak Securities on Feb 26, 2026

Tata Chemicals Limited has scheduled a meeting with Kotak Securities Limited on February 26, 2026, in Mumbai. This is an investor meet intimation. No Unpublished Price Sensitive Information will be shared during the meeting.

Tata Chemicals Q3FY26: Transcript of Analysts Call Released

Tata Chemicals released its Q3FY26 analyst call transcript. Global soda ash demand is tepid due to macroeconomic factors, though India shows robust growth. Consolidated revenue was ₹3,550 crore, with EBITDA at ₹345 crore, impacted by subdued U.S. pricing. Standalone revenue rose 3% to ₹1,204 crore, with EBITDA up 9% to ₹228 crore. Key investments include a ₹515 crore salt facility in Tamil Nadu and acquisitions.

Fitch Affirms Tata Chemicals' Credit Rating at BB+ (Stable Outlook)

Fitch Ratings has affirmed Tata Chemicals Limited’s Long Term Foreign Currency Issuer Default Rating (IDR) at BB+ with a Stable Outlook. The rating was affirmed on February 6, 2026, following an update to Fitch's Corporate Rating Criteria.

Tata Chemicals to Invest ₹515 Crore in New IVSD Plant in Tamil Nadu

Tata Chemicals will invest ₹515 crore to set up a new greenfield manufacturing facility for Iodised Vacuum Salt Dried (IVSD) in Tamil Nadu. The plant will have a capacity of 210 KTPA and is expected to be completed within 36 months. This expansion aims to strengthen supply chain and improve regional distribution.

Tata Chemicals Q3 FY26 Results: Consolidated Loss of ₹69 Crore, Standalone Profit of ₹73 Crore

Tata Chemicals reported a consolidated loss of ₹69 crore for Q3 FY26, down from a profit of ₹154 crore in Q3 FY25. Standalone profit was ₹73 crore, up from ₹72 crore. Consolidated revenue was ₹3,550 crore, and standalone revenue was ₹1,204 crore for the quarter ended December 31, 2025.

Tata Chemicals Q3 FY26 Earnings Call Audio Recording Available

Tata Chemicals released the audio recording for its Q3 FY26 earnings call. The call, held on February 2, 2026, discussed unaudited consolidated and audited standalone financial results for the period ending December 31, 2025. The results were approved by the Board on the same day.

Tata Chemicals Approves ₹515 Crore Greenfield Salt Facility in Tamil Nadu

Tata Chemicals approved a ₹515 crore investment for a new greenfield IVSD manufacturing facility in Tamil Nadu with a 210 KTPA capacity. The project, to be completed in 36 months, aims to improve supply chain efficiency and optimize logistics. The Board approved this on February 2, 2026.

Tata Chemicals Q3FY26 Results: Revenue ₹3,550 Cr, PAT ₹(15) Cr

Tata Chemicals reported Q3FY26 consolidated revenue of ₹3,550 crore and a PAT of ₹(15) crore. For the nine months ended December 31, 2025, revenue was ₹11,146 crore and PAT was ₹520 crore. The company highlighted lower soda ash realisations as a key factor. Several capacity expansions and acquisitions are underway, including a new salt plant in the UK and a Bi-carb plant in Singapore.

Tata Chemicals Q3FY26: Board Approves Unaudited Consolidated & Audited Standalone Financial Results

Tata Chemicals Limited's Board of Directors approved the unaudited consolidated and audited standalone financial results for the quarter and nine months ended December 31, 2025. The results were reviewed by B S R & Co. LLP.

Tata Chemicals Schedules Q3 FY26 Earnings Call for Feb 2, 2026

Tata Chemicals will hold an investor call on February 2, 2026, at 7:00 PM IST to discuss Q3 and 9M FY26 financial results for the period ending December 31, 2025. The call will feature the MD & CEO and CFO.

Tata Chemicals Announces Senior Management Changes

Tata Chemicals announces senior management changes. Mr. K. R. Venkatadri, Chief Commercial Officer, will retire on March 31, 2026. Mr. Alok Chandra will become Chief Commercial Officer from April 1, 2026. Mr. Narasimha V. Kamath and Mr. Rajesh Kamat will take new roles effective February 1, 2026.

Tata Chemicals Files SEBI Compliance Certificate for Q3 FY26

Tata Chemicals Limited submitted a SEBI compliance certificate for the quarter ended December 31, 2025. The company confirmed that details of securities dematerialized/rematerialized were furnished to stock exchanges as per SEBI regulations.

Tata Chemicals to acquire Novabay Pte. for EUR 25 Million

Tata Chemicals International Pte. Limited will acquire 100% of Novabay Pte. Limited for EUR 25 Million. Novabay, a Singapore-based firm, manufactures premium grade sodium bicarbonate for pharma, food, and personal care. The acquisition aims to strengthen Tata Chemicals' presence in high-value product segments and is expected to complete by March 2026.

Tata Chemicals Allots ₹1,500 Crore NCDs with 7.06% Coupon

Tata Chemicals Limited has allotted ₹1,500 crore of listed Non-Convertible Debentures (NCDs) on December 17, 2025. The NCDs have a tenor of 2 years 364 days and a fixed coupon rate of 7.06%. The allotment was made to identified investors on a private placement basis.

Tata Chemicals to Raise ₹1,500 Crore via Unsecured NCDs on Private Placement

Tata Chemicals will issue listed, unsecured NCDs worth ₹1,500 crore via private placement. The issuance comprises 1,50,000 NCDs with a face value of ₹1,00,000 each. Allotment is scheduled for December 20, 2025, with maturity in approximately 3 years. The NCDs carry a "CARE AA+/Stable" and "CRISIL AA+/Stable" rating.

Tata Chemicals Announces Special Window for Physical Share Re-lodgement

Tata Chemicals announces a special window from July 7, 2025, to January 6, 2026, for re-lodgement of physical share transfer requests lodged before April 1, 2019, that faced rejection due to deficiencies.

CRISIL assigns/re-affirms Tata Chemicals' credit ratings

CRISIL assigns/re-affirms ratings for Tata Chemicals: CRISIL AA+/Stable for ₹1,200cr NCDs (assigned), CRISIL AA+/Stable for ₹1,700cr NCDs (re-affirmed), and CRISIL A1+ for ₹100cr Commercial Paper (re-affirmed).

CARE Ratings assigns/re-affirms Tata Chemicals' credit ratings

CARE Ratings assigns/re-affirms ratings for Tata Chemicals' NCDs and bank facilities. NCDs (₹1,500 crore) assigned CARE AA+; Stable. NCDs (₹1,700 crore), Long Term (₹1,300 crore), and Short Term (₹2,000 crore) bank facilities re-affirmed.

Tata Chemicals Announces Key Management Personnel Changes and Authorizations

Tata Chemicals announces the superannuation of Mr. Rajiv Chandan and the appointment of Mr. Jeraz E. Mahernosh as Company Secretary and Compliance Officer, effective December 1, 2025. Key managerial personnel are authorized for disclosures.

Tata Chemicals approves ₹910 crore investment for capacity expansion

Tata Chemicals approves ₹910 crore investment for capacity expansion of soda ash and precipitated silica plants to meet growing demand, to be completed over the next 24-27 months.

Tata Chemicals' US subsidiary fined USD 20,400 by Wyoming DEQ for calciner test failure

Tata Chemicals' US subsidiary, TCSAP, was fined USD 20,400 (₹17.02 lakh) by Wyoming DEQ for a calciner test failure in June-August 2023. The company expects no material financial impact.

Tata Chemicals Releases Q2 & H1 FY26 Earnings Call Transcript, Discusses Mixed Results and Growth Plans

Tata Chemicals released Q2 & H1 FY26 earnings call transcript. Standalone results were strong, but consolidated saw one-time impacts. Global soda ash market faces headwinds, but India growth plans are underway.

Tata Chemicals Releases Audio Recording of Q2/H1 FY26 Earnings Call

Tata Chemicals released the audio recording of its Analysts/Investors Call held on November 3, 2025, discussing Q2 and H1 FY26 financial results, which were approved by the Board on November 1, 2025.

Tata Chemicals Reports Mixed Q2 & Half-Year FY26 Financial Results

Tata Chemicals reported mixed Q2 FY26 results. Consolidated profit after tax fell to ₹154 crore YoY, while standalone profit after tax rose to ₹178 crore. Half-year consolidated profit improved.

Tata Chemicals Reports Q2 & H1 FY26 Results, Faces Soda Ash Pricing Pressure

Tata Chemicals reports mixed Q2/H1 FY26 results with consolidated revenue and EBITDA decline but H1 PAT growth. Faces weak global soda ash prices due to oversupply, but sees long-term positive trends.

Tata Chemicals Q2FY26: Revenue ₹3,877 Cr, EBITDA ₹537 Cr

Tata Chemicals Q2FY26: Consolidated revenue at ₹3,877 Cr, down 3% YoY; EBITDA at ₹537 Cr. Standalone revenue up 19% YoY at ₹1,204 Cr, with EBITDA up 67% at ₹240 Cr.

Tata Chemicals Approves Unaudited Q2 & H1 FY26 Results, NCD Issuance

Tata Chemicals approved Q2 & H1 FY26 results and fund raising via NCDs up to ₹1,500 crore through private placement.

Tata Chemicals Board Approves Q2 & Half-Year Results, ₹1,500 Cr Fundraise

Tata Chemicals board approves unaudited consolidated and audited standalone financial results for the quarter ended September 30, 2025. Approved raising upto ₹1,500 Cr through NCDs.

Tata Chemicals wins court case; ₹783 crore demand ruled illegal

Tata Chemicals' subsidiary, TCML, wins a court case in Nairobi against the County Government of Kajiado, with a demand of ₹783 crore being ruled as arbitrary and illegal.

Tata Chemicals notifies schedule of Analyst/Institutional Investor Meetings

Tata Chemicals announced the schedule of meetings with Analysts/Institutional Investors on November 7, 12 and 17, 2025. No Unpublished Price Sensitive Information will be shared during the meetings.

Tata Chemicals Announces Analyst/Investor Call for Q2 & H1 FY26 Results

Tata Chemicals to conduct an analyst/investor call on November 3, 2025, at 4:30 PM IST to discuss Q2 & H1 FY26 financial results. MD & CEO and CFO will represent the company.

Tata Chemicals Opens Special Window for Re-lodgement of Physical Share Transfer Requests

Tata Chemicals has opened a special window from July 7, 2025, to January 6, 2026, for shareholders to re-lodge previously rejected physical share transfer requests, as per a SEBI circular.

CARE Ratings Reaffirms Tata Chemicals' Credit Ratings with Stable Outlook

CARE Ratings reaffirmed Tata Chemicals' credit ratings: AA+ Stable for NCDs and long-term bank facilities, and A1+ for short-term bank facilities, indicating strong financial health.

Tata Chemicals submits SEBI Regulation 74(5) certificate for Q3FY25

Tata Chemicals submitted the Regulation 74(5) certificate for Q3FY25, confirming dematerialization/rematerialization details to exchanges for the quarter ended September 30, 2025.

Tata Chemicals announces new email ID for RTA, MUFG Intime India

Tata Chemicals appoints Jeraz E. Mahernosh as Company Secretary & Compliance Officer

Tata Chemicals: 'Saksham Niveshak' Campaign for KYC Update and Unclaimed Dividends

Tata Chemicals announces resignation of Chief Human Resource Officer, Mr. Rahul Pinjarkar

Tata Chemicals reports strong profit growth in Q1 FY26; comprehensive income turns positive

Tata Chemicals releases audio recording of Q1 FY26 financial results analyst call

Tata Chemicals Q1FY26: Revenue ₹3,719 Cr, PAT ₹316 Cr

Tata Chemicals adopts revised Code of Corporate Disclosure Practices and Legitimate Purpose Policy

Tata Chemicals Reports Strong Q1 FY26 Profit Growth, Consolidated PAT Up 80.5% to ₹316 Crore